According to the results of our study, the use of Losartan adjunctive therapy for diabetic macular edema (DME) was not more effective than the standard treatment (intravitreal injection of antivascular endothelial growth factor (Anti-VEGF)). Here, VEGFA is linked to diabetic macular edema.